Nā ʻano hoʻololi hoʻolālā Nanostructure Peptide: He Alakaʻi ʻanuʻu

Pane wikiwiki

Control peptide nanostructure design variables step by step: kaʻina, uku ʻupena, kūlana hui, counterions, nā lepili, a me ka maemae.

He aha ka mea i helu ʻia ma ke ʻano he Peptide Nanostructure Design Variable

ʻO kahi peptide nanostructure hoʻolālā hoʻololi kekahi ʻāpana e hoʻololi i ka mea kemika a i ʻole nā ​​kūlana i hui ʻia ma lalo, a ke helu wale ʻia ʻo ia i hoʻomalu ʻia ke haʻi ʻoe me kēlā mau kūlana. ʻO ka hui ʻana iho ʻo ia ka hui kūʻokoʻa o nā molekole peptide i loko o nā hale i kauoha ʻia; ʻO kahi nanostructure ka hui hopena ma ka pālākiō nanometer. ʻO ka hoʻopili koʻikoʻi koʻikoʻi (CAC) ʻo ia ka paepae paepae i hoʻokumu ʻia ai nā hui, a he paepae maoli ia ma mua o ka hoʻokō: i loko o nā ʻōnaehana amyloid-type ka helu lua-nucleation e pili ana i ka neʻe ʻana o ka monomer a me ka ʻike fibril koʻikoʻi o ka nui. 10 nM, ʻoiai no ka semaglutide kahi koʻikoʻi koʻikoʻi o nā puʻupuʻu peptide e hoʻoulu i ka ulu autocatalytic i nā pule (Nā mea nano, 2022).

Nā ʻano hoʻololi hoʻolālā Nanostructure Peptide: He Alakaʻi ʻanuʻu

ʻEono mau ʻano hoʻololi i ka hapa nui o ka huikau i ka peptide self-assembly characterization: kaʻina, uku ʻupena, kūlana hui, ʻike kūʻē, lepili kemika, a me ka maemae. ʻAʻole nā ​​​​counterions he footnote i kēlā papa inoa. Ke pale nei lākou i ka hoʻopiʻi peptide e ka ion-pairing me nā koena kumu a me ka termini, a ua hōʻike ʻia ʻo TFA e pili pū me ka pediocin PA-1, ke keʻakeʻa nei i ka nānā ʻana i ke kūkulu ʻana a me ka hoʻonui iki ʻana i ka maʻiʻo α-helical (Nā biomolele, 2025). Hiki ke hoʻololi ka ʻike counter-ion i ke ala hui, ʻaʻole wale ka hopena: Hoʻonui ʻia ka hoʻokumu ʻana o Aβ fibril me Cl⁻ me ka paʻakai TFA, a ʻike ʻia kahi ala waena α-helical me TFA⁻ wale nō (Nā lāʻau lapaʻau, 2020).

ʻO ia ke kumu e hiki ai i nā pepa ʻelua ke hōʻike i kahi "antimicrobial peptide nanofiber" a wehewehe i nā mea like ʻole..

Ki Takeaway: ʻO kahi hoʻololi hoʻolālā he mea hoʻololi wale nō ke hōʻike pū ʻia me nā kūlana i hoʻonohonoho ʻia.

Nā ʻano hoʻololi hoʻolālā Nanostructure Peptide: He Alakaʻi ʻanuʻu

No ke aha i kaohi ʻole ʻia ʻo Peptide Nanostructure Design Variables i haki i ka hoʻohālikelike haʻawina Cross-study

ʻAʻole paʻa ka hoʻohālikelike haʻawina keʻa no ka mea ʻaʻole paʻa mau nā ʻano, ʻaʻole no ka mea ʻaʻole hiki ke hana hou ʻia ka biology kumu. I ka noonoo ana, pH, ka wela a me ka ikaika ionic ma waena o nā hōʻike, Hiki i nā pepa ʻelua ke wehewehe i ke kaʻina like a ke ana mau nei i nā ʻōnaehana like ʻole. ʻO ka hopena kūpono, ʻo ka ʻokoʻa morphology i hoʻopili ʻia i ka hoʻolālā kaʻina e hōʻike paha i kahi buffer i ʻōlelo ʻole ʻia a i ʻole ka manaʻo hana ʻē aʻe..

Hiki ke hōʻike ʻia ke āpau ma mua o ka hypothetical. ʻO kahi loiloi e hōʻike ana i nā kūlana i koi ʻia a haʻalele iā lākou i ka papa inoa o ka manaʻo, pH, ka mahana a me ka ikaika ionic e like me nā kūlana hoʻokolohua pono, a laila hōʻike i kāna Aib oligopeptide, pyrenyl-pentapeptide a me nā ʻōnaehana hihia LB-film me ka ʻole o lākou. ʻAʻohe ʻano loiloi ʻōnaehana e helu ana i ka manawa i loaʻa ai kēia, no laila e mālama i kēia ma ke ʻano he hōʻike hōʻike ʻana, ʻaʻole i ana ʻia.

He kaʻina hana ka hoʻoponopono: E mālama i kēlā me kēia hoʻololi hoʻolālā ma ke ʻano he ʻāpana i hoʻopaʻa ʻia me kahi waiwai i ʻōlelo ʻia a me kahi ʻano hana ʻole, ʻo ia ka mea i kuhikuhi ʻia e nā ʻanuʻu ma lalo nei.

Ma mua o kou hoʻomaka ʻana: Nā mea e pono ai no kahi Panel Peptide Hoʻohālikelike

he papa kuhikuhi e hōʻike ana i nā mea kani a me nā mea e pono ai ma mua o ka hoʻomaka ʻana - HPLC, nuipaʻa spectrometer, CD spectrometer, hoʻopuehu māmā i

Hoʻohālikelike ʻia kahi panel inā hoʻokomo kēlā me kēia pūʻulu iā ia ma ke ʻano he mea kemika kikoʻī piha, ʻaʻole he kaula leka, me ka maemae, nuipa i hoʻopaʻa ʻia, counterion a i ʻole ke ʻano paʻakai a me ka ʻike i hoʻopaʻa ʻia me ke kaʻina (Hoʻomaʻamaʻa hōʻike kaʻina peptide). E hōʻuluʻulu i kēlā palapala ma mua o ka synthesis mua, ʻaʻole ma hope o ka hoʻāʻo hope.

ʻO kāu mea e pono ai:

  • Nā mea hana a me ke komo ʻana: RP-HPLC me kahi kolamu i kākau ʻia a me ka gradient; LC-MS no ka hōʻoia nui; dichroism pōʻai no ka heluhelu ʻana i ke kūkulu lua; hoʻopuehu māmā ikaika a i ʻole SAXS no ka puʻunaue nui; Loaʻa iā TEM a i ʻole AFM no ka morphology.

  • Reagents a me nā kūlana: counterion-exchange resin a i ʻole ka paʻakai o ke ʻano i manaʻo ʻia, me nā kūlana kuhikuhi no ka maʻemaʻe a me ka calibration nuipaʻa.

  • ʻIke i manaʻo ʻia: solid-phase peptide synthesis terminology a me ka hana maʻamau biophysical. Inā he mea hou ʻoe i ke kaʻina hana, e hana ma o ka peptide hoʻohuihui ponoʻī kumu mua.

  • Manawa: ma kahi o ʻelua a ʻehā pule no kēlā me kēia panel, hoʻomalu ʻia e ka synthesis a me ka hoʻomaʻemaʻe orthogonal hōʻoia.

  • Nā lawelawe Ka pilikia: waena a hiki i mua.

Hōʻike kumu. ʻO ka ʻO ke alakaʻi alakaʻi EMA e mana i Iune 2026 uhi i ka hana synthetic-peptide, hōʻailona, nā kikoʻī a me ka mana analytical, a ke manaʻo nei ia e hōʻike ʻia nā hopena hōʻike ma kahi counter-ion-free, kumu anhydrous. ʻO kēlā hui ka mea e hoʻohālikelike ai ka peptide antimicrobial a me ka hōʻoia analytical i nā labs, no laila e aʻo mai ka hoʻomaka.

Kūikawā: nā paepae haumia i ʻōlelo pinepine ʻia ma ke ʻano he hōʻike >0.1%, hoʻomaopopo >0.5% a kūpono >1.0% he mau helu hana wale nō. E hōʻoia iā lākou e kūʻē i ke alakaʻi PDF ma mua o kou kākau ʻana iā lākou i kahi kikoʻī.

ʻanuʻu 1: Wehewehe i ke Kaʻina ma ke ʻano he Hui Kemika, ʻAʻole kahi kaula leka

I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi moʻolelo kūkulu piha i hiki i ka mea heluhelu ʻelua ke hana hou i ka mole mai ia mea wale nō. ʻAʻole kēlā moʻolelo ʻo ke kaula kaʻina leka hoʻokahi. Haʻalele ia i kēlā me kēia hoʻololi e hoʻololi i ka nuipa, uku, a i ʻole ke ʻano hui pū, ʻo ia ke kumu e hiki ai i nā labs ʻelua ke hōʻike i ka "sequence" like a loaʻa i nā nanostructure ʻokoʻa.

Kākau i ka moʻolelo ma ka ʻōlelo N→C a hoʻokaʻaʻike i kēlā me kēia me kēia me ka maopopo:

  1. Kaʻikala. Hōʻike i ke ʻano (poo-a-huelo, kaulahao ʻaoʻao-a-ʻaoʻao, disulfide) a me nā kūlana hoʻopaʻa pololei.

  2. Hoʻopaʻa paʻa. Hāʻawi i nā kūlana stapling a me ka mea hoʻohui kemika, ʻaʻole wale "stapled".

  3. Nā kūlana D-koena. E papa inoa i kēlā me kēia ma ka helu kūlana.

  4. Lipidation. E inoa i ka ʻike lipid a me ka pūnaewele hoʻopili.

  5. Nā pāpale kuʻina. E hoʻopaʻa i ka acetylation N-terminal (Ac-) a me C-terminal amidation (-NH2) kahi e noho nei.

  6. ʻIke pūʻulu. Hoʻohui i ka maʻemaʻe, nuipa i hoʻopaʻa ʻia, ʻano kūʻē a paʻakai paha, a me ka peptide maʻiʻo no ka nui kikoʻī.

E mālama i kēia hohonu hōʻike ma ke ʻano he manaʻo hōʻike i hoʻopaʻa ʻia mai ka hui maʻamau, ʻaʻole ma ke ʻano he maʻamau i paʻi ʻia. ʻO ka ʻaha kūkā ʻo ia ka N→C peptide sequence notation i wehewehe ʻia i loko o nā mea kuhikuhi e like me ka Bionity peptide sequence entry., a ʻo nā mea ʻike pūʻulu e hahai i ka loina like: Hoʻohālikelike ʻia ke kūkulu ʻana ke hele pū kona mau ʻano i ana ʻia.

Hoʻohuihui Peptide Hooia: e hāʻawi i ka moʻolelo i kahi hoa hana i ʻike ʻole i ka noi synthesis. Inā hiki iā lākou ke kaha kiʻi i ka hui kemika piha, me kēlā me kēia hoʻololi a me kona kūlana, pau ka mooolelo. Inā pono lākou e nīnau i ke ʻano o ka "cyclized" ma aneʻi, ʻaʻole ia.

No ke kōkua: ʻO ka moʻolelo kūkulu ka ʻāpana o ka hoʻohālikelike. Inā ʻokoʻa nā moʻolelo ʻelua i ka hohonu o ka wehewehe, ua huikau ka hoohalike ana mamua o ka holo ana o kekahi hoao ana.

ʻanuʻu 2: E hōʻike i ka uku ʻupena ma ka pH Assay, ʻAʻole ka uku inoa

I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi kumukūʻai uku ʻupena i hōʻike ʻia ma kahi inoa ʻO nā Peptides Synthetic ʻano pH a me ka paʻakai, ʻaʻole kahi helu i kope ʻia mai kahi helu helu.

ʻO ka uku ʻupena he pH-pili, waiwai pale-pale, no laila, ʻaʻole i hoʻololi i ka hoʻolālā ʻana ka inoa "+8".. Noho pū ʻo Charge ma kahi ʻāpana kūʻai aku ma mua o ka pōmaikaʻi monotonic. Ma hoʻokahi moʻo V13K, e hoʻonui ana i ka uku ʻupena mai +8 i +9 ua hui pū ʻia me ka piʻi ʻana o ka hana hemolytic ma mua o 32, me HC50 e hāʻule ana mai 250 µg/mL i lalo 7.8 µg/mL, a +8 hāʻawi i ke kaulike therapeutic maikaʻi loa i kēlā pūʻulu hoʻokahi (Nā hopena o ka uku ʻupena a me ka helu o nā koena i hoʻopaʻa ʻia, Biopolymers, 2008/2010). Aia ka uku ʻoi loa ma mua o ka piʻi ʻana o ka hemolysis.

Hooia: ʻO nā inoa moʻolelo pH a me ka paʻakai e pili ana i ka uku.

ʻanuʻu 3: Hoʻoponopono i nā Kūlana Hui Pū ʻIa a hōʻike i ka Concentration Hoʻohui Koʻikoʻi

I ka pau ʻana o kēia ʻanuʻu, loaʻa iā ʻoe kahi protocol hui i kākau ʻia e hōʻike ana i ka manaʻo, pH, ikaika ionic, a me ka mahana, a me ka hoʻopaʻa ʻana o ka hoʻohui koʻikoʻi (CAC) no kēlā me kēia kaʻina. Hoʻonohonoho ʻia ka Morphology e kēia mau kūlana, no laila, ʻo kahi kūlana i hōʻike ʻole ʻia he hana hiki ʻole ke hana hou ʻia, ʻaʻole i haʻalele iki.

ʻO ke kumu o nā kūlana i loko o ka papa hoʻololi ʻo ia ke hiki i nā counter-ions ke hoʻokele pono iā ia iho. A 2025 loiloi ma Nā biomolele e pili ana i nā hopena o nā counter-ions ma ka peptide structure a me nā hōʻike hana e hui pū ai nā peptides amphiphilic i ka ʻike ʻana i nā molekole i hoʻopiʻi ʻia a i ʻole nā ​​​​counter-ions., ʻO nā peptides acidic e hana i nā nanofibers ma lalo o nā kūlana acidic a i ʻole ma o ka pilina electrostatic me nā counter-ions, a ʻo kēlā Ca²⁺, trifluoroacetate, a me ka waika formic ua hōʻike ʻia kēlā me kēia e hoʻoikaika i ka peptide a me ka hoʻokumu ʻana o ka dimer protein ma HPLC. Ma ka hana, ʻo ia hoʻi, ʻo ka paʻakai i loko o kāu buffer a me ka counter-ion i waiho ʻia mai ka hoʻomaʻemaʻe ʻana, ʻo ia nā mea hoʻololi hui. Hana ʻia ʻo Peptide

E hōʻike i ka CAC ma ke ʻano he ana me kāna ʻano, no ka mea, hōʻailona ia i ka hoʻopaʻa ʻana ma luna aʻe e lilo ai ka hui i ka hoʻoikaika ʻana ma mua o ke kaʻina. No ka wehewehe a me ka nui i hōʻike ʻia, e ʻike i ka ʻāpana taxonomy ma luna.

Hooia: E hāʻawi i ka protocol i kahi hoa hana i ʻike ʻole i kāu puke. Inā hiki iā lākou ke holo i ka ʻanuʻu hui me ka nīnau ʻole iā ʻoe i hoʻokahi nīnau, pau ka pauku.

ʻanuʻu 4: E mālama i ka Counterion Exchange ma ke ʻano he ʻanuʻu ʻole ʻoe e ana

I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi pae counterion koena ma kahi o kahi i manaʻo ʻia. Kakaʻikahi ka pau ʻana o ka hoʻololi kūʻē, ʻo ia ka mea e hoʻopiʻi ai i ka paʻakai ma ka lepili vial ma mua o ka hopena. A 2020 ka nānā ʻana i nā hopena counter-ion i nā peptides hōʻike i ka hapa nui o nā ala i paʻi ʻia a hiki i 98% hoʻololi ma hope o kekahi mau hana hou ʻana, a ʻo ka waika hydrochloric dissolution a me ka lyophilisation ala "ʻaʻole e hāʻawi i kahi wehe TFA piha a hoʻololi i nā chlorides.,” me nā meheu i ʻike ʻia (ʻO ke kuleana o nā Counter-Ions ma nā Peptides, 2020).

E mālama i kēlā koena ma ke ʻano he hoʻololi hoʻolālā i kona pono ponoʻī. E hōʻike i ka maʻiʻo counterion i ana ma ka ʻaoʻao o ke ʻano paʻakai āu e koi nei, me ka hoʻohana ʻana i ke ʻano like a me ka pūʻulu like āu i hoʻouna ai i ka assay.

Hooia: ʻike ʻia ka pae counterion koena i kāu mau moʻolelo me ke ʻano paʻakai, ʻaʻole ma ke ʻano he footnote iā ia.

ʻanuʻu 5: E koho a hōʻoia i ka lepili ma mua o ka hilinaʻi ʻana i kekahi heluhelu i hoʻopaʻa ʻia

kahi ʻaoʻao-ʻaoʻao CD spectra overlay o ka peptide i hōʻailona ʻia a me ka lepili ʻole e hōʻike ana i nā pihi kokoke like., hui pū ʻia me nā hopena hemolysis ʻokoʻa

Hiki i ka fluorophore ke hoʻololi i ka ʻawaʻawa i ana ʻia me ka hoʻololi ʻole i ka spectrum CD. I loko o kahi papa peptide hana membrane, conjugation i ka hydrophobic a i ʻole nā ​​fluorophores i hoʻopiʻi maikaʻi ʻia (RhB, Q570, TF3) Ua hoʻonui nui ʻia ka hemolytic toxicity pili i ka peptide unlabeled, ʻoiai ua hāʻawi liʻiliʻi ka CF i hoʻopiʻi ʻole ʻia; circular dichroism ʻaʻole i hōʻike ʻia ka ʻokoʻa lua ma waena o nā ʻano lepili a me nā ʻano lepa ʻole, no laila i ʻike ʻole ʻia ka manaʻo i ka heluhelu ʻana (He aha ka nui o nā Fluorophores Bias i ka hana olaola o nā Peptides?, Bioeng Biotechnol i mua, 2020). ʻO ke kānāwai kūpono: mai hoʻohālikelike i ka hana i hōʻailona ʻia me ka hana ʻole ʻia mai kahi kūkulu ʻē aʻe. Holo i nā ʻano ʻelua mai ka pūʻulu hoʻokahi, a mālama i nā hopena lepili peptide ma ka hui ʻana ma ke ʻano he loli āu e ana, ʻaʻole he mea hoʻolaha kūʻokoʻa āu e manaʻo ai.

No ke kōkua: Inā loaʻa mai nā ʻano lepili a me ka lepili ʻole mai nā ʻāpana ʻokoʻa, ʻAʻole hiki iā ʻoe ke hoʻokaʻawale i ka hōʻailona hōʻailona mai nā ʻano like ʻole. E hoʻokaʻawale i hoʻokahi ʻāpana synthesis ma mua o ka hui ʻana.

ʻanuʻu 6: E hoʻokumu i ka maʻemaʻe ma kahi kumu Net-Content a hōʻoia iā ia ma ke ʻano Orthogonally

he chromatogram RP-HPLC i hōʻike ʻia me ka piko nui, ʻO nā piko haumia a me ka laina kumu hoʻohui i kaha ʻia, pili i ka intact-mass spectr

I ka pau ʻana o kēia ʻanuʻu, e loaʻa iā ʻoe kahi helu maʻemaʻe hiki iā ʻoe ke pale i ka loiloi, ʻaʻole he pākēneka ʻāpana wale nō mai hoʻokahi chromatogram.

ʻO ka pākēneka o ka ʻāpana HPLC ʻaʻole he ʻike peptide net. ʻO ka pākēneka o ka ʻāpana e helu ana i nā mea e hoʻoheheʻe ʻia e UV i kāu puka aniani; ʻaʻohe mea e pili ana i nā counterions, wai koena, a i ʻole ka hakina nui ʻo ia kāu kaʻina. ʻO ke kiʻi pinepine ʻia o "95% maʻemaʻe e HPLC akā wale nō 70% peptide by mass" e holo nei ma ke ʻano he kumu kūʻai aku me ka ʻole o ka waihona kumu mua ma hope o ia, no laila e mālama iā ia ma ke ʻano he hana kūpono ma mua o ka helu helu. ʻO ka helu pale ʻia ʻo ka ʻikepili peptide net: ka hopena ho'āʻo i hōʻike ʻia ma kahi counter-ion-free, kumu anhydrous, ʻO ia ke kumu e koi ai ka European Medicines Agency no ka hōʻike ʻana i ka peptide assay i kāna alakaʻi i nā peptides synthetic..

ʻIke ʻia kēlā me kēia ala i kahi ʻāpana ʻokoʻa o ka hāpana, ʻo ia ke kumu i lawa ʻole ai kekahi:

  • LC-MS paʻa-nuipaʻa hōʻoia i ka molecular mass o nā ʻano nui a hōʻailona i nā hoʻololi nui, akā ʻaʻole hiki iā ia ke ʻike i kahi isomer co-eluting o ka nui like.

  • LC-MS/MS peptide palapala palapala localizes sequence-level defects like deamidation, ʻoki ʻana, a i ʻole kahi hoʻohui i hala, a ʻo ia wale nō ke ala maʻamau e haʻi iā ʻoe i hea hewa kekahi kaʻina.

  • Ka nānā ʻana i ka ʻakika amino hāʻawi i ka ratio haku mele a, me kahi maʻamau calibrated, he waiwai maʻiʻo piha, ʻaʻole hiki iā ia ke hoʻokaʻawale i ke kaʻina isomer.

  • Hoʻokaʻawale Orthogonal (hoʻololi ion a i ʻole electrophoresis capillary hale kūʻai me RP-HPLC) hoʻoholo i nā mea i hui pū ʻia ma lalo o hoʻokahi mīkini.

  • ʻO ka dichroism pōʻai a me ka FTIR hōʻike i ke kūkulu lua, aole maemae, a me DLS a i ʻole TEM/AFM hōʻike mokuʻāina, ʻaʻole ʻike kemika. E hoʻohana iā lākou e hōʻoia i ke ʻano o ke kūkulu ʻana e like me ka mea i hoʻolālā ʻia, ʻaʻole loa he hōʻike maʻemaʻe.

No ka maʻemaʻe peptide antimicrobial a me ka hōʻoia analytical, ʻO ke kānāwai kūpono, ʻo ka helu helu ʻupena a me hoʻokahi hōʻoia orthogonal ka liʻiliʻi loa.. Hoʻokahi ʻāpana RP-HPLC ma 220 ʻo ka nm he wahi hoʻomaka, ʻaʻole kahi kikoʻī hoʻokuʻu.

Inā makemake ʻia ka mea no ka hoʻohana injectable, ʻelua mau palena compendial e pili ana ma luna o ka maʻemaʻe kemika. ʻO nā palena ʻāpana i loko USP <788> e hoʻonoho i nā paepae hoʻopololei ʻaʻole ʻoi aku ma mua o 6,000 nā ʻāpana o kēlā me kēia pahu ma 10 µm a nui aʻe a 600 no ka pahu ma 25 µm a ʻoi aku paha no ka hoʻoheheʻe liʻiliʻi, hoopaa ana i 25 ʻāpana/mL a 3 particles/mL no ka nui-volume injections. Hoʻokaʻawale ʻia ʻo Endotoxin e ka helu K/M endotoxin palena ma USP <85>, kahi o EL = K/M a me K 5 USP-EU/kg no nā ala ʻē aʻe ma waho o intrathecal a 0.2 USP-EU/kg no intrathecal. Hoʻopaʻa ʻia nā mea ʻelua me ka nui a me ke ala, no laila aia lākou i ka kikoʻī ma mua o ka hoʻokuʻu ʻia ʻana o ka pūʻulu mua, ʻaʻole ma hope o ka nānā ʻole ʻana i ka sterility.

Hooia: hōʻike i kahi helu maʻiʻo upena ma kahi counter-ion-free, kumu anhydrous, inoa i ke ʻano orthogonal i hōʻoia ʻia, a e haʻi i nā palena hoʻopaʻi e pili ana inā makemake ʻia ka mea no ka injection.

Nā hewa maʻamau e hōʻalo ai

ʻO ka hāʻule pinepine ma kēia kahua ʻo ka hōʻike ʻana i kahi uku nominal a me kahi maʻemaʻe nominal me he mea lā ua ana ʻia nā mea ʻelua.. Loaʻa i kēlā me kēia kuhi hewa ma lalo nei kahi ʻano hemahema i kākau ʻia a me kahi hoʻoponopono kikoʻī.

ʻO ka haʻi ʻana i ka uku nominal ma mua o ka pH i ʻōlelo ʻia. Heluhelu ʻia ka uku nominal mai ke kaʻina; ʻO ka uku i ʻike maoli ʻia e ka assay ma muli o nā koina pKa kaulahao ʻaoʻao a me ka pH buffer. ʻO ka hoʻoponopono e helu a hōʻike i ka uku ʻupena ma ka pH assay, me ka mea paahana a me kona mana i kapaia.

Ke manaʻo nei ua pau ka hoʻololi counterion. Hiki ke hoʻomau ka Trifluoroacetate mai ka hoʻomaʻemaʻe RP-HPLC ma o ka lyophilization, ka hoʻololi ʻana i ka nuipa a me ka hana ʻike. ʻO ka hoʻoponopono ʻana ʻo ke ana ʻana i nā maʻiʻo counterion koena ma mua o ka manaʻo ua pau ka hoʻololi.

Ka hoʻohālikelike ʻana i nā mea i hoʻopaʻa ʻia a me ka lepili ʻole ʻia ma nā pūʻulu like ʻole. Hoʻololi ka fluorophore a i ʻole affinity tag i ka hydrophobicity a me ka ʻano hui pū, no laila, ʻaʻole like ka hui kemika me kona makua. ʻO ka hoʻoponopono e hoʻohālikelike i loko o hoʻokahi pūʻulu a i ʻole e haʻi i ka lepili ma ke ʻano he ʻokoʻa.

Ka mālama ʻana i ka pākēneka o ka wahi RP-HPLC ma ke ʻano he peptide content. Helu chromophore ka pākēneka ʻāpana, ʻaʻole ka nui o ka peptide, no laila e hoʻonui i ka ʻike i ka wā e kūʻē ai, wai, a i ʻole nā ​​huahana ʻokiʻoki i loaʻa. ʻO ka hoʻoponopono ʻana ʻo ka hoʻokumu ʻana i ka maʻemaʻe peptide antimicrobial a me ka hōʻoia analytical ma ke kumu ʻupena a nānā iā ia me ka orthogonally.

Haalele ana i ka noonoo, pH, ikaika ionic, a me ka mahana mai ka protocol hui. Hoʻonohonoho kēia mau ʻāpana ʻehā i ke ala hui, a ʻo ka waiho ʻana i kekahi o lākou me ka ʻole i hōʻike ʻia e hana i ka nanostructure i hōʻike ʻole ʻia. ʻO ka hoʻoponopono e hōʻike i nā ʻehā no kēlā me kēia hoʻomākaukau.

⚠️ ʻŌlelo Aʻo: ʻO kahi waiwai i lawe ʻia i loko o ka papa hoʻohālikelike e lilo i mea hoʻololi hoʻopunipuni hoʻopunipuni.

Pehea ka holomua

Inā ua hahai ʻia ke kaʻina hana, ʻO kēlā me kēia kūkulu i loko o ka panel e lawe i kahi moʻolelo kaʻina, he uku ʻupena i hōʻike ʻia ma kahi pH assay i wehewehe ʻia, he ʻano paʻakai i ʻōlelo ʻia me ke koena counterion, he protocol hui i palapala ʻia me ka manaʻo koʻikoʻi o ka hōʻuluʻulu ʻana kahi e kūpono ai ka ʻaha, he paʻa hoʻopaʻa inoa ʻole ʻia, a me kahi helu hoʻomaʻemaʻe ʻupena i hoʻopaʻa ʻia e kahi ʻano orthogonal. ʻO kēlā mau huahana ʻeono ka mea e pale ai ka panel: hiki i kekahi mea loiloi ke ʻimi i kahi ʻano i hōʻike ʻia i nā kūlana i hoʻopuka ai ma mua o kahi paʻamau i ʻōlelo ʻole ʻia.

ʻO ka pahuhopu e hoʻolōʻihi i ka panel i kahi ʻano counterion ʻelua o ke kaʻina like a hoʻāʻo i ka neʻe ʻana o ke ala hui.. ʻO ka Aβ chloride versus trifluoroacetate hoʻohālikelike ʻo ia ka hihia kuhikuhi no ke kumu kūpono ke nīnau ʻana i kēlā nīnau., ʻoiai ʻo ka counterion wale nō i hoʻoneʻe i ka ʻano hui i ʻike ʻia.

Nīnau pinepine

He aha ka mea e hoʻomalu ai i ka hana ʻana o kahi peptide i nā fibers a i ʻole vesicles?

ʻO ke kaulike ma waena o ke ʻano hydrophobic a me ka hydrophilic ma ke kaʻina, ka uku ʻupena ma ka pH assay, a me nā kūlana hui āu i kau ai ma Steps 2 a 3 ʻO nā ʻano like ʻole e pili mau ana i ka morphology i nānā ʻia. Hōʻike nā hōʻike e hiki i nā loli liʻiliʻi i kekahi o lākou ke neʻe i kahi peptide ma waena o nā morphologies, ʻo ia ke kumu e hiki ai ke hōʻike ʻia ke kaʻina like me nā hopena like ʻole ma nā labs. ʻO ka pane kūpono ʻaʻohe mea hoʻololi hoʻokahi e hoʻomalu i ka hopena, no laila e hōʻike pū iā lākou a pau ma mua o ka hoʻohui ʻana i ka hopena i hoʻokahi.

Hiki iaʻu ke hoʻololi i kahi kemika lepili ʻē aʻe inā ʻaʻole i loaʻa ka mea aʻu i hoʻolālā ai?

Hiki iā ʻoe, akā inā ʻoe e holo hou i ka hōʻoia ma Step 5 no ka mea pani, no ka mea, ʻo ka hoʻopaʻa inoa ʻana ma ka hui ʻana he chemistry-specific a ʻaʻole i hoʻololi ʻia kahi heluhelu i hoʻopaʻa ʻia no kekahi lepili i kekahi.. Hiki i ka lepili i ʻae ʻia no hoʻokahi peptide ke hoʻopilikia i ka hui ʻana iho a i ʻole ka heluhelu biological no kekahi. E mālama i ka hoʻololi ʻana ma ke ʻano he hoʻololi hoʻolālā hou ma mua o ka hoʻololi like-for-like.

He aha kaʻu e hana ai inā kū ka counterion exchange ma lalo o ka pahuhopu?

E hōʻoia i ka hale kūʻai maoli ma mua o ka hoʻololi ʻana i kekahi mea: ana i ke koena counterion maʻiʻo ma ka upena maʻiʻo, e like me ka Step 6, ma mua o ka hoʻomaopopo ʻana i ka hoʻopau ʻana mai ka helu o nā pōʻai hoʻololi. Inā ʻaʻole i hoʻokō maoli ʻia ka pahuhopu, hōʻike i ka waiwai i loaʻa a me nā kūlana hoʻololi ma kahi o ka waiwai i manaʻo ʻia. ʻO kahi hui i hoʻololi ʻole ʻia he mokuʻāina hiki ke hōʻike ʻia, ʻaʻole he hoʻokolohua hāʻule.

Pehea ka hopena o ka manawa EMA i ka hana e holo nei?

ʻAʻole i mana ke alakaʻi, no laila, ʻaʻole i hoʻopau ʻia nā haʻawina e hana nei, akā, ʻo ka haumia a me ke ʻano o nā mea i manaʻo ʻia ʻo ia ke kuhikuhi o ka huakaʻi. Kahi e hiki ai iā ʻoe ke hoʻohana i ka ʻupena-maʻiʻo a me nā hana hōʻoia orthogonal i ka Step 6 i kēia manawa, liʻiliʻi ke kumu kūʻai a hoʻemi i ka hana hou ma hope. E mālama i nā paepae o kēia manawa ma ke ʻano he manawa kūpono a hiki i ka hōʻoia ʻana o ke kikokikona alakaʻi hope.

Pau nā paepae haumia?

ʻAʻole. ʻO nā paepae i kuhikuhi ʻia i loko o kēia alakaʻi he mea kūʻokoʻa a pono e hōʻoia ʻia e kūʻē i ke alakaʻi PDF ma mua o kou hilinaʻi ʻana iā lākou no ka hoʻoholo hoʻokuʻu.. A hiki i kēlā hōʻoia, e hoʻohana iā lākou ma ke ʻano he pahuhopu hoʻolālā ma mua o ka palena hoʻokō, a palapala i ka mana āu i hana ai.

Nā ʻanuʻu aʻe

Loaʻa iā ʻoe kahi papa inoa e hoʻohuli i kahi kaʻina peptide i kahi kūkulu like: he mea kemika i hoomaopopoia, ka uku ma ka pH assay, nā kūlana hui hoʻomalu me ka hōʻike koʻikoʻi koʻikoʻi koʻikoʻi, maʻiʻo counterion ana, he lepili i hooiaioia, a me ka hoʻomaʻemaʻe i hoʻopaʻa ʻia ma ke kumu net-content. ʻO nā kūkulu hoʻohālikelike ka mea e hiki ai i nā koi hoʻohālikelike like, a ʻo kēlā aʻo ʻana ke kumu o ka hana hilinaʻi ma nā peptide nanostrategies e kūʻē i ka maʻi kūʻē i ka lāʻau. E pili ana

Loaʻa i ka MOL Changes kahi hoihoi pāʻoihana i nā kūlana maikaʻi peptide, a me kāna pūʻolo analytical palapala i nā ʻāpana a kēia alakaʻi e noi ai iā ʻoe e hōʻike. Inā makemake ʻoe e ʻike pehea i hoʻonohonoho ʻia ai kēlā palapala, e nānā i ka pūʻolo analytical no ke kaʻina hōʻike.

ʻO kēlā me kēia unuhi lapaʻau a lapaʻau paha i kūkākūkā ʻia ma ʻaneʻi he pōʻaiapili preclinical. E kamaʻilio i kahi ʻoihana kūpono ma mua o ka hoʻohana ʻana i kēia mau hana a i ʻole nā ​​​​mea i ʻike ʻia i ka hana maʻi.

Nānā ʻia e [inoa], Ph.D., Kemika Analytical.

Kaʻina aʻe: E ʻike pehea i kākau ʻia ai ka maikaʻi o ka peptide. E noʻonoʻo i ka pūʻolo analytical, a laila palapala ʻāina i kēlā me kēia palapala hōʻoia o ka mahina ʻana i nā ʻāpana i nā Steps 2, 4, a 6 o keia alakai.

Zejun Peng

Zejun Peng

Luna ʻenehana Nui; ʻO ka mea akamai i ka peptide Synthesis Kaʻike kumu: ʻO ka peptide synthesis paʻakikī, nā hoʻololi ʻana o ka amino acid kūlohelohe, a me ke kūkulu ʻana i nā peptides cyclic a me nā peptides stapled.

moʻokalaleo:He ʻike nui ʻo Zejun Peng i ka kemika kūlohelohe a me ka synthesis peptide. Maikaʻi ʻo ia i ka hoʻohana ʻana o ka solid-phase peptide synthesis (SPSS) a me ka peptide synthesis wai (LPPS), a akamai loa i ka lanakila ʻana i nā "paʻakikī loa-e-synthesize sequences" (e like me nā peptides ultra-long-chain, nā kaʻina hydrophobic kiʻekiʻe, a me ka pelu ana i na mea paa disulfide lehulehu). Ma lalo o kāna alakaʻi, ua lanakila ka hui i nā bottlenecks ʻenehana i kekahi mau hoʻololi kūikawā (e like me ka N-methylation, PEGylation, a me ka lepili fluorescent), ka mālama ʻana i ka helu kūleʻa synthesis o luna 98%.

ʻIke ʻia & Nā alakaʻi hoʻoponopono
Nānā ʻia e: Ka poe akamai kumuhana
Kaʻana like i kēia ʻatikala
Home Huli Whatsapp Nā lawelawe Huahana